Breaking the Silence: Sexual Health Help for Men with Cancer

About 90% of men that undergo prostate cancer treatment, and almost 50% of men treated for different kinds of cancer suffer a degree of sexual dysfunction or erectile challenges. Most hardly ever open up about these issues and they suffer in silence. This needn't be so, because there are many ways through which sexual challenges can be addressed for men with cancer. As the quest for better cancer treatments that have minimal side effects progresses at companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI), there is hope that innovative therapies can reduce the prevalence of such debilitating side effects. The news release from BioMedWire highlights the critical need for open conversations about sexual health during cancer treatment, emphasizing that men should not suffer in silence. It underscores that effective solutions exist, from counseling to medical interventions, but stigma often prevents men from seeking help. The article also points to ongoing research and development by companies like Calidi Biotherapeutics, which is working on novel cancer treatments that may minimize sexual side effects. By breaking the taboo and encouraging dialogue, patients can improve their quality of life. BioMedWire, a specialized communications platform under the Dynamic Brand Portfolio @ IBN, delivers this message through its network of wire solutions via InvestorWire and editorial syndication to 5,000+ outlets. The platform aims to cut through information overload, bringing attention to critical issues like sexual health in cancer care. For more details, readers are directed to the full article on BioMedWire's website.